Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
Teva must face government's kickback claims over Copaxone - judge | Reuters
Teva Is Easy Pill to Swallow - WSJ
20 States Accuse Generic Drug Companies of Price Fixing - The New York Times
Gilead, Teva and J&J's HIV antitrust case inches closer to trial
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
Ranbaxy, Teva settle US anti-competition case | Mint
Teva neck-deep in legal trouble with no end in sight | Ctech
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Antitrust: Commission sends Statement of Objections to Teva on 'pay for delay' pharma agreement
Men's Original Universal Urban – Sports Basement
Antitrust: Commission fines Teva and Cephalon €60.5 million
Case studies in Strategy: Teva
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Q1 2023 Earnings: A Mix Of Challenges And Opportunities | Seeking Alpha
Statement by Executive Vice-President Margrethe Vestager on the Commission decision to fine Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine - PubAffairs Bruxelles
Case studies in Strategy: Teva
Gilead And Teva's HIV Antitrust Trial Begins
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Court denies Teva's motion to dismiss Copaxone kickbacks case - Globes
Teva Hit With New Lawsuit Over Proposed Korlym Drug Copy
DEF 14A
Teva settles Cephalon case with FTC for $1.2 billion over sleep drug - The Boston Globe
